Prot# H8K-MC-JZAD: A Phase 2 Study of LY573636-sodium Administered as Second-Line or Third-Line Treatment in Patients with Unresectable or Metastatic Soft Tissue Sarcoma

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/23/07 → 8/23/10

Funding

  • Eli Lilly and Company (H8K-MC-JZAD)